Company Registration No. 7381295 (England and Wales)
IBERO CARIBBEAN HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
IBERO CARIBBEAN HEALTHCARE LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
IBERO CARIBBEAN HEALTHCARE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
-
-
Creditors: amounts falling due within one year
3
(9,020)
(8,540)
Net current liabilities
(9,020)
(8,540)
Capital and reserves
Called up share capital
128,304
128,304
Profit and loss reserves
(137,324)
(136,844)
Total equity
(9,020)
(8,540)

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 5 May 2026 and are signed on its behalf by:
J S Simon-Zurita
Director
Company registration number 7381295 (England and Wales)
IBERO CARIBBEAN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Ibero Caribbean Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 9 Bonhill Street, London, EC2A 4DJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, rounded to the nearest £.

The financial statements have been prepared on the historical cost convention except for the modification to a fair value basis for certain financial instruments as specified in the accounting policies below.

1.2
Going concern

The company is dependent on financial support from related parties who have undertaken to support the company for the foreseeable future. Consequently, the accounts have been prepared on the going concern basis. The directors intend to wind down the company within the next 12 months as there is no trade.

1.3
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. It only has financial assets and financial liabilities of a kind that qualify as basic financial instruments.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method less any impairment.

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or the risks and rewards of ownership are transferred.

Basic financial Liabilities

Basic financial liabilities, including trade and other payables, are initially recognised at transaction price and subsequently measured at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

IBERO CARIBBEAN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

There are no employees during the year other than the directors.

3
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
9,020
8,540
4
Control

The ultimate controlling party is Calais de Inversiones S.L., a company incorporated in Spain.

2025-09-30 2024-10-01 false false false 05 May 2026 CCH Software CCH Accounts Production 2025.100 No description of principal activity B Brauch J S Simon-Zurita 0 7381295 2024-10-01 2025-09-30 7381295 2025-09-30 7381295 2024-09-30 7381295 core:ShareCapital 2025-09-30 7381295 core:ShareCapital 2024-09-30 7381295 core:RetainedEarningsAccumulatedLosses 2025-09-30 7381295 core:RetainedEarningsAccumulatedLosses 2024-09-30 7381295 bus:Director2 2024-10-01 2025-09-30 7381295 core:CurrentFinancialInstruments 2025-09-30 7381295 core:CurrentFinancialInstruments 2024-09-30 7381295 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 7381295 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 7381295 bus:FRS102 2024-10-01 2025-09-30 7381295 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 7381295 bus:Director1 2024-10-01 2025-09-30 7381295 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP